Thromboserin Ltd. is an ‘innovator’ research company and their mission is to focus primarily on preventing arterial thrombosis. TH001 was granted a US Patent in December 2015, giving them IP until 2030.
"We have always been impressed by the standard of the work delivered by the Niche team. In addition, the contracting process is simple and efficient, communication is open, frequent and proactive, with any issues getting resolved quickly and efficiently."
Thromboserin first approached Niche to create the Investigator's Brochure (IB) for their product, TH001. This was particularly challenging as the information provided by the original Sponsor was poor quality and in hard copy only. Niche's renowned expertise in the writing of IBs ensured the quick and effective delivery of this document which was used to inform Thromboserin’s Protocol and subsequently used to build their Clinical Trial Application. Niche also aided Thromboserin’s search for development partners to support the company in their clinical development.
EVERSANA is a leading independent provider of global services to the life sciences industry. The company’s integrated.
read moreDemeRx is a US-based clinical stage pharmaceutical development company advancing drug candidates as therapies for.
read moreErytech Pharma SA is a clinical-stage biopharmaceutical company based in Lyon, France, best known for its proprietary.
read moreFollowing the acquisition of Strimvelis and associated gene therapy assets by Orchard Therapeutics, our contributions.
read moreFunxional Therapeutics Ltd was a privately-held pharmaceutical start-up. It was set up in 2005 to commercialise the.
read moreHOOKIPA Pharma is a small but ambitious company with a pioneering vision for their arenavirus platform
read moreiOnctura is a clinical-stage biopharmaceutical company that benefited from our history with oncology indications, to.
read moreNanomerics’ mission is to deliver augmented medicines with improved activity and fewer associated side effects through.
read moreVectivBio has evolved from a small biotech in engaged in early development into an organisation actively planning and.
read moreGet our latest news and publications
Sign up to our news letterResources
Social
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
